Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-14,730
Closed -$346K 666
2014
Q4
$346K Hold
14,730
0.01% 508
2014
Q3
$335K Buy
14,730
+130
+0.9% +$2.96K 0.01% 512
2014
Q2
$357K Buy
14,600
+385
+3% +$9.41K 0.01% 501
2014
Q1
$300K Sell
14,215
-100
-0.7% -$2.11K 0.01% 512
2013
Q4
$341K Sell
14,315
-2,550
-15% -$60.7K 0.01% 496
2013
Q3
$361K Sell
16,865
-4,300
-20% -$92K 0.01% 480
2013
Q2
$421K Buy
+21,165
New +$421K 0.01% 443

Other funds holding QGENF

Pinnacle Associates's QGENF Position: Q1 2015 in Review

Pinnacle Associates sold out of QIAGEN NV (QGENF) in Q1 2015, closing a stake of 14,730 shares — an estimated $346K sold.

Pinnacle Associates first reported a position in QGENF in Q2 2013 and held it in 7 quarters. The position peaked at $421K in Q2 2013. 175 funds tracked by Wall St. Rank hold QGENF as of Q1 2015.

  • Pinnacle Associates reported no remaining QIAGEN NV position as of Q1 2015 after selling out during the quarter.
  • Pinnacle Associates sold 14,730 QIAGEN NV shares in Q1 2015, an estimated $346K.
  • Pinnacle Associates first reported a position in QIAGEN NV in Q2 2013 and held it in 7 quarters.
  • Pinnacle Associates's QIAGEN NV position peaked at $421K in Q2 2013.
  • 175 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2015.

Based on Pinnacle Associates's 13F filing for Q1 2015, filed 15 May 2015.